Biological factors of response to erythropoiesis-stimulating agents in low/int-1 grade MDS

被引：0
|
作者：
Pawlikowska, P.
Kosmider, O. [1 ]
Park, S. [1 ]
Bardet, V. [1 ]
Kuhnowsky, F.
Pierre-Eugene, C.
Picard, F.
Viallon, V.
Viguie, F. [2 ]
Mayeux, P.
Lacombe, C. [1 ]
Porteu, F.
Dreyfus, F. [1 ]
Fontenay, M. [1 ]
机构：
[1] Univ Paris 05, Hop Cochin, APHP, INSERM,U567, Paris, France
[2] Univ Paris 05, Hotel Dieu, APHP, Paris, France
来源：
LEUKEMIA RESEARCH | 2009年 / 33卷
关键词：
D O I：
10.1016/S0145-2126(09)70072-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S51 / S52
页数：2
相关论文
共 50 条
  • [1] p-ERK1/2 is a predictive factor of response to erythropoiesis-stimulating agents in low/int-1 myelodysplastic syndromes
    Frisan, Emilie
    Pawlikowska, Patrycja
    Pierre-Eugene, Cecile
    Viallon, Vivian
    Gibault, Laure
    Park, Sophie
    Mayeux, Patrick
    Dreyfus, Francois
    Porteu, Francoise
    Fontenay, Michaela
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (11): : 1964 - 1968
  • [2] Efficacy and Safety of Imetelstat in RBC Transfusion-Dependent (TD) IPSS Low/Int-1 MDS Relapsed/Refractory to Erythropoiesis-Stimulating Agents (ESA) (IMerge)
    Fenaux, Pierre
    Raza, Azra
    Vellenga, Edo
    Platzbecker, Uwe
    Santini, Valeria
    Samarina, Irina
    Van Eygen, Koen
    Diez-Campelo, Maria
    Patnaik, Mrinal M.
    Sherman, Laurie
    Sun, Libo
    Varsos, Helen
    Rose, Esther
    Rizo, Aleksandra
    Steensma, David P.
    BLOOD, 2017, 130
  • [3] EFFECTS OF ERYTHROPOIESIS-STIMULATING AGENTS ON OVERALL SURVIVAL OF IPSS LOW/INT-1 RISK TRANSFUSION INDEPENDENT MYELODYSPLASTIC SYNDROMEPATIENTS, A FISM STUDY
    Messa, E.
    Gioia, D.
    Masiera, E.
    Castiglione, A.
    Ceccarelli, M.
    Salvi, F.
    Danise, P.
    Sanna, A.
    Allione, B.
    Balleari, E.
    Poloni, A.
    Cametti, G.
    Ferrero, D.
    Tassara, R.
    Finelli, C.
    Bonferroni, M.
    Ciccone, G.
    Saglio, G.
    Levis, A.
    Santini, V.
    LEUKEMIA RESEARCH, 2017, 55 : S58 - S58
  • [4] Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis
    Hernandez-Boluda, Juan-Carlos
    Correa, Juan-Gonzalo
    Garcia-Delgado, Regina
    Martinez-Lopez, Joaquin
    Alvarez-Larran, Alberto
    Fox, Maria-Laura
    Garcia-Gutierrez, Valentin
    Perez-Encinas, Manuel
    Ferrer-Marin, Francisca
    Mata-Vazquez, Maria-Isabel
    Raya, Jose-Maria
    Estrada, Natalia
    Garcia, Silvia
    Kerguelen, Ana
    Duran, Maria-Antonia
    Albors, Manuel
    Cervantes, Francisco
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (04) : 407 - 414
  • [5] Erythropoiesis stimulating agents and other growth factors in low-risk MDS
    Hellstrom-Lindberg, Eva p
    van de Loosdrecht, Arjan
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (04) : 401 - 410
  • [6] Selenium Associates With Response to Erythropoiesis-Stimulating Agents in Hemodialysis Patients
    Yasukawa, Minoru
    Arai, Shigeyuki
    Nagura, Michito
    Kido, Ryo
    Asakawa, Shinichiro
    Hirohama, Daigoro
    Yamazaki, Osamu
    Tamura, Yoshifuru
    Fujimaki, Michitaka
    Kobayashi, Sawako
    Mimaki, Masakazu
    Kodama, Hiroko
    Uchida, Shunya
    Fujigaki, Yoshihide
    Shibata, Shigeru
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (07): : 1565 - 1574
  • [7] Biological functions and therapeutic use of erythropoiesis-stimulating agents: perplexities and perspectives
    Merchionne, Francesca
    Dammacco, Franco
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (02) : 127 - 141
  • [8] Validation of Predictive Models for Response to Erythropoiesis-Stimulating Agents in Myelodysplastic Syndromes
    Gowanlock, Zachary
    Sriram, Swetha
    Martin, Alison
    Lazo-Langner, Alejandro
    BLOOD, 2015, 126 (23)
  • [9] Dialysis adequacy and response to erythropoiesis-stimulating agents: What is the evidence base?
    Locatelli, Francesco
    Del Vecchio, Lucia
    Pozzoni, Pietro
    Andrulli, Sirneone
    SEMINARS IN NEPHROLOGY, 2006, 26 (04) : 269 - 274
  • [10] Erythropoiesis-stimulating agents in elderly patients with anemia: response and cardiovascular outcomes
    Gowanlock, Zachary
    Sriram, Swetha
    Martin, Alison
    Xenocostas, Anargyros
    Lazo-Langner, Alejandro
    BLOOD ADVANCES, 2017, 1 (19) : 1538 - 1545
12345